Olema Pharmaceuticals (OLMA) finance VP reports initial stock and option stakes
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Olema Pharmaceuticals, Inc. executive Austin Sasha Lu, the VP of Finance and Controller, filed an initial ownership report detailing equity holdings in the company. As of January 30, 2026, Lu directly holds 4,488 shares of common stock and multiple stock option awards. These stock options are structured to vest monthly over multi‑year periods, with several grants featuring 25% vesting on specified initial dates and the remaining 75% vesting in equal monthly installments, all contingent on continued service with Olema.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Austin Sasha Lu
Role
VP of Finance and Controller
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,000 shares (Direct);
Common Stock — 4,488 shares (Direct)
Footnotes (1)
- 25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. The shares underlying the option shall vest monthly over a four-year period commencing on April 3, 2023, with 1/48 of the shares vesting on the one-month anniversary of April 3, 2023 and the remainder of the shares vesting in equal installments on each one-month anniversary date thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. 25% of the shares subject to the option vested on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
FAQ
What does the Form 3 filing by Olema Pharmaceuticals (OLMA) report for Austin Sasha Lu?
The Form 3 reports Austin Sasha Lu’s initial ownership in Olema. It shows direct holdings of common stock and several stock option awards, each with time-based vesting schedules tied to ongoing employment with the company.
What types of securities are included in Austin Sasha Lu’s Olema (OLMA) holdings?
Austin Sasha Lu’s holdings include Olema common stock and several stock option awards. The options are described as “Stock Option (Right to Buy)” and are subject to specific vesting schedules over multi‑year periods, dependent on continued service.
How do Austin Sasha Lu’s Olema (OLMA) stock options vest over time?
The stock options vest in stages over four-year periods. Some grants vest 25% on a specified date, with the remaining 75% vesting in equal monthly installments, provided Lu continues serving Olema through each vesting date.
Does the Olema (OLMA) Form 3 show any stock being bought or sold by Austin Sasha Lu?
The Form 3 does not report clear buy or sell transactions. Instead, it lists existing holdings of common stock and stock options, with transactions classified as holdings and transaction directions marked as unknown in the summary data.